fda stops semaglutide compounding Hims & Hers launched a $49 weight loss pill last week, offering a compounded version of semaglutide, the active ingredient in approved drugs like Wegovy. Just 48 hours later, the company Patients Cut Off From Cheaper

Understanding these factors is useful for patients who may be considering participation in a trial or who wish to discuss emerging therapies with their healthcare provider

She has also found the process of drawing the medication up from a vial challenging after years of using prefilled injector pens

Pawlak et al

Personalized treatment options For patients with cancers like breast, ovarian, pancreatic and prostate, identifying genetic mutations (like BRCA mutations) can open the door to personalized therapies

If you are looking for a deeper dive into GLP-1 agonists and how they work, adverse effects, and drug interactions, take a listen to this podcast

Follow-up Re-check IGF-1 and metabolic markers after 6-8 weeks or after meaningful protocol changes